{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cancer", "Epidemiology", "Gynecology", "Mortality", "Risk factor"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36757546", "DateCompleted": {"Year": "2023", "Month": "02", "Day": "13"}, "DateRevised": {"Year": "2023", "Month": "03", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "02", "Day": "09"}], "Language": ["eng"], "ELocationID": ["10.1007/s12032-023-01957-3"], "Journal": {"ISSN": "1559-131X", "JournalIssue": {"Volume": "40", "Issue": "3", "PubDate": {"Year": "2023", "Month": "Feb", "Day": "09"}}, "Title": "Medical oncology (Northwood, London, England)", "ISOAbbreviation": "Med Oncol"}, "ArticleTitle": "Epidemiological trends and risk factors of gynecological cancers: an update.", "Pagination": {"StartPage": "93", "MedlinePgn": "93"}, "Abstract": {"AbstractText": ["Gynecological cancers, the most common cancer among women worldwide, disrupt the function of women's reproductive system, significantly impacting the quality of life. The epidemiological patterns of gynecological cancers differ in various regions and alter over time. The main challenge to deal with women's cancers is focusing on potential plans to improve patient outcomes. The epidemiology and general risk elements of gynecological cancers are important in the management of these cancers, so all of the reported risk factors in gynecological cancers have been evaluated in the present review. Due to the role of gynecological cancers in women's health, preventive measures and modifiable lifestyles together with early detection in high-risk groups are effective strategies that can reduce mortality rates. This review summarizes the epidemiology and global risk factors of gynecological cancers alongside others to better management of these malignancies and improve the quality of life in the affected patients."], "CopyrightInformation": "\u00a9 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran."}, {"Identifier": [], "Affiliation": "Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Keyvani", "ForeName": "Vahideh", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Genetics and Molecular Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Kheradmand", "ForeName": "Nahid", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Genetics and Molecular Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Navaei", "ForeName": "Zahra Nasrpour", "Initials": "ZN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Mollazadeh", "ForeName": "Samaneh", "Initials": "S"}, {"Identifier": ["0000-0002-9371-4170"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Bu-Ali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran. Imunoman2009@gmail.com."}, {"Identifier": [], "Affiliation": "Immunology Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Imunoman2009@gmail.com."}], "LastName": "Esmaeili", "ForeName": "Seyed-Alireza", "Initials": "SA"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Med Oncol", "NlmUniqueID": "9435512", "ISSNLinking": "1357-0560"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["epidemiology", "pathology"], "DescriptorName": "Genital Neoplasms, Female"}, {"QualifierName": [], "DescriptorName": "Quality of Life"}, {"QualifierName": [], "DescriptorName": "Risk Factors"}, {"QualifierName": [], "DescriptorName": "Life Style"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Society AC. Cancer facts & figures. The Society; 2008."}, {"Citation": "Siddeek RAT, Gupta A, Gupta S, Goyal B, Gupta AK, Agrawal S, et al. Evaluation of platelet distribution width as novel biomarker in gall bladder cancer. J Carcinogenesis. 2020;19:5.", "ArticleIdList": ["10.4103/jcar.JCar_12_20"]}, {"Citation": "Control CfD. Prevention. Inside knowledge: Get the facts about gynecologic cancers. 2015;2014."}, {"Citation": "Hashemipour M, Boroumand H, Mollazadeh S, Tajiknia V, Nourollahzadeh Z, Borj MR, et al. Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers. Gynecol Oncol. 2021;161(1):314\u201327.", "ArticleIdList": ["33581845", "10.1016/j.ygyno.2021.02.004"]}, {"Citation": "Goker A, Guvenal T, Yanikkerem E, Turhan A, Koyuncu F. Quality of life in women with gynecologic cancer in Turkey. Asian Pac J Cancer Prev. 2011;12(11):3121\u20138.", "ArticleIdList": ["22394001"]}, {"Citation": "Terzio\u011flu F, Alan H. The effect of some psychological problems experienced during gynecological cancer treatment upon women\u2019s sexual life. Anadolu Hem\u015firelik ve Sa\u011fl\u0131k Bilimleri Dergisi. 2015;18(2):140\u20137."}, {"Citation": "Tetteh DA. \u201cI feel different\u201d: ovarian cancer and sexual self-concept. Women\u2019s Reproductive Health. 2017;4(1):61\u201373.", "ArticleIdList": ["10.1080/23293691.2017.1276371"]}, {"Citation": "CDC. Gynecologic cancers. 2017. www.cdc.gov/cancer/gynecologic/ ."}, {"Citation": "Pieterse Q, Maas C, Ter Kuile M, Lowik M, Van Eijkeren M, Trimbos J, et al. An observational longitudinal study to evaluate miction, defecation, and sexual function after radical hysterectomy with pelvic lymphadenectomy for early-stage cervical cancer. Int J Gynecol Cancer. 2006;16(3):1119\u201329.", "ArticleIdList": ["16803495", "10.1136/ijgc-00009577-200605000-00027"]}, {"Citation": "Cleary V, Hegarty J, McCarthy G, Eds. Sexuality in Irish women with gynecologic cancer. Oncol Nurs Forum. 2011;38:87\u201396."}, {"Citation": "Jensen PT, Groenvold M, Klee MC, Thranov I, Petersen MA, Machin D. Early-stage cervical carcinoma, radical hysterectomy, and sexual function: a longitudinal study. Cancer. 2004;100(1):97\u2013106.", "ArticleIdList": ["14692029", "10.1002/cncr.11877"]}, {"Citation": "Oskay \u00dcY, Beji NK, Bal MD, Y\u0131lmaz SD. Evaluation of sexual function in patients with gynecologic cancer and evidence-based nursing interventions. Sex Disabil. 2011;29(1):33\u201341.", "ArticleIdList": ["10.1007/s11195-010-9188-y"]}, {"Citation": "Reis N, Beji NK, Coskun A. Quality of life and sexual functioning in gynecological cancer patients: results from quantitative and qualitative data. Eur J Oncol Nurs. 2010;14(2):137\u201346.", "ArticleIdList": ["19836305", "10.1016/j.ejon.2009.09.004"]}, {"Citation": "Bal MD, Yilmaz SD, Beji NK. Sexual health in patients with gynecological cancer: a qualitative study. Sex Disabil. 2013;31(1):83\u201392.", "ArticleIdList": ["10.1007/s11195-012-9263-7"]}, {"Citation": "Cleary V, Hegarty J. Understanding sexuality in women with gynaecological cancer. Eur J Oncol Nurs. 2011;15(1):38\u201345.", "ArticleIdList": ["20584629", "10.1016/j.ejon.2010.05.008"]}, {"Citation": "Cory L, Morgan MA. Pathology consultation for the gynecologic oncologist: what the surgeon wants to know. Arch Pathol Lab Med. 2018;142(12):1503\u20138.", "ArticleIdList": ["30133316", "10.5858/arpa.2018-0122-RA"]}, {"Citation": "SIegel RL, et al. Cancer statistics. CA Cancer J Clin. 2018;68:7\u201330.", "ArticleIdList": ["29313949"]}, {"Citation": "Cokkinides V, Albano J, Samuels A, Ward M, Thum J. American cancer society: cancer facts and figures. Atlanta: American Cancer Society; 2005."}, {"Citation": "Colon SJ. Human papillomavirus and cervical cancer. 2018."}, {"Citation": "Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https://doi.org/10.3322/caac.21660 .", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Keyvani V, Farshchian M, Esmaeili S-A, Yari H, Moghbeli M, Nezhad S-RK, et al. Ovarian cancer stem cells and targeted therapy. J Ovarian Res. 2019;12(1):1\u201311.", "ArticleIdList": ["10.1186/s13048-019-0588-z"]}, {"Citation": "Institute NC. Cancer stat facts: ovarian cancer. 2018."}, {"Citation": "Abbaszadegan MR, Taghehchian N, Aarabi A, Akbari F, Saburi E, Moghbeli M. MAEL as a diagnostic marker for the early detection of esophageal squamous cell carcinoma. Diagn Pathol. 2021;16(1):36. https://doi.org/10.1186/s13000-021-01098-z .", "ArticleIdList": ["10.1186/s13000-021-01098-z", "33902648", "8077922"]}, {"Citation": "Abbaszadegan MR, Taghehchian N, Aarabi A, Moghbeli M. MAEL Cancer-testis antigen as a diagnostic marker in primary stages of gastric cancer with helicobacter pylori infection. J Gastrointest Cancer. 2020;51(1):17\u201322. https://doi.org/10.1007/s12029-018-0183-3 .", "ArticleIdList": ["10.1007/s12029-018-0183-3", "30488287"]}, {"Citation": "Forghanifard MM, Naeimi Khorasanizadeh P, Abbaszadegan MR, Javdani Mallak A, Moghbeli M. Role of DIDO1 in progression of esophageal squamous cell carcinoma. J Gastrointest Cancer. 2020;51(1):83\u20137. https://doi.org/10.1007/s12029-019-00212-1 .", "ArticleIdList": ["10.1007/s12029-019-00212-1", "30761474"]}, {"Citation": "Jiang X, Tang H, Chen T. Epidemiology of gynecologic cancers in China. J Gynecol Oncol. 2018;29(1):e7. https://doi.org/10.3802/jgo.2018.29.e7 .", "ArticleIdList": ["10.3802/jgo.2018.29.e7", "29185265"]}, {"Citation": "Health NIo. National cancer institute: surveillance, epidemiology, and end results program. Cancer Stat Facts: Uterine Cancer. 2019."}, {"Citation": "Yang T, Cairns BJ, Allen N, Sweetland S, Reeves GK, Beral V. Postmenopausal endometrial cancer risk and body size in early life and middle age: prospective cohort study. Br J Cancer. 2012;107(1):169\u201375.", "ArticleIdList": ["22644298", "3389421", "10.1038/bjc.2012.229"]}, {"Citation": "Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity among adults and youth: United States, 2015\u20132016. 2017."}, {"Citation": "Ledford LR, Lockwood S. Scope and epidemiology of gynecologic cancers: an overview. Semin Oncol Nurs. 2019;35:147\u201350.", "ArticleIdList": ["30902519", "10.1016/j.soncn.2019.03.002"]}, {"Citation": "Quinn BA, Deng X, Colton A, Bandyopadhyay D, Carter JS, Fields EC. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival. Brachytherapy. 2019;18(1):29\u201337.", "ArticleIdList": ["30361045", "10.1016/j.brachy.2018.08.016"]}, {"Citation": "Harper EI, Sheedy EF, Stack MS. With great age comes great metastatic ability: ovarian cancer and the appeal of the aging peritoneal microenvironment. Cancers. 2018;10(7):230.", "ArticleIdList": ["29996539", "6070816", "10.3390/cancers10070230"]}, {"Citation": "Pellerin GP, Finan MA. Endometrial cancer in women 45 years of age or younger: a clinicopathological analysis. Am J Obstet Gynecol. 2005;193(5):1640\u20134.", "ArticleIdList": ["16260203", "10.1016/j.ajog.2005.05.003"]}, {"Citation": "Strander B, H\u00e4llgren J, Spar\u00e9n P. Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality. BMJ. 2014;348:f7361.", "ArticleIdList": ["24423603", "3898577", "10.1136/bmj.f7361"]}, {"Citation": "El Ibrahimi S, Pinheiro PS. The effect of marriage on stage at diagnosis and survival in women with cervical cancer. Psychooncology. 2017;26(5):704\u201310.", "ArticleIdList": ["26810012", "10.1002/pon.4070"]}, {"Citation": "Alterman T, Burnett C, Peipins L, Lalich N, Halperin W. Occupation and cervical cancer: an opportunity for prevention. J Womens Health. 1997;6(6):649\u201357.", "ArticleIdList": ["9437639", "10.1089/jwh.1997.6.649"]}, {"Citation": "Le ND, Leung A, Brooks-Wilson A, Gallagher RP, Swenerton KD, Demers PA, et al. Occupational exposure and ovarian cancer risk. Cancer Causes Control. 2014;25(7):829\u201341.", "ArticleIdList": ["24728670", "10.1007/s10552-014-0384-4"]}, {"Citation": "Shao Z, Zhu T, Zhang P, Wen Q, Li D, Wang S. Association of financial status and the quality of life in Chinese women with recurrent ovarian cancer. Health Qual Life Outcomes. 2017;15(1):144.", "ArticleIdList": ["28716032", "5512840", "10.1186/s12955-017-0714-9"]}, {"Citation": "Madison T, Schottenfeld D, James SA, Schwartz AG, Gruber SB. Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival. Am J Public Health. 2004;94(12):2104\u201311.", "ArticleIdList": ["15569961", "1448599", "10.2105/AJPH.94.12.2104"]}, {"Citation": "Derakhshan A, Manshaei G, Afshar H, Goli F. Effect of a bioenergy economy program on pain control, depression, and anxiety in patients with migraine headache. Int J Body Mind Culture. 2016:30\u201345."}, {"Citation": "Barchitta M, Maugeri A, Quattrocchi A, Agrifoglio O, Scalisi A, Agodi A. The association of dietary patterns with high-risk human papillomavirus infection and cervical cancer: a cross-sectional study in Italy. Nutrients. 2018;10(4):469.", "ArticleIdList": ["29641467", "5946254", "10.3390/nu10040469"]}, {"Citation": "Campbell CL, Campbell LC. A systematic review of cognitive behavioral interventions in advanced cancer. Patient Educ Couns. 2012;89(1):15\u201324.", "ArticleIdList": ["22796302", "3462275", "10.1016/j.pec.2012.06.019"]}, {"Citation": "Yazdanpanah E, Mahmoudi M, Sahebari M, Rezaieyazdi Z, Esmaeili SA, Tabasi N, et al. Vitamin D3 alters the expression of toll-like receptors in peripheral blood mononuclear cells of patients with systemic lupus erythematosus. J Cell Biochem. 2017;118(12):4831\u20135.", "ArticleIdList": ["28544067", "10.1002/jcb.26155"]}, {"Citation": "Garc\u00eda-Closas R, Castellsagu\u00e9 X, Bosch X, Gonz\u00e1lez CA. The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence. Int J Cancer. 2005;117(4):629\u201337.", "ArticleIdList": ["15912536", "10.1002/ijc.21193"]}, {"Citation": "Ocalewski J, Michalska P, Izdebski P, Jankowski M, Zegarski W. Fear of cancer progression and health behaviors in patients with colorectal cancer. Am J Health Behav. 2021;45(1):138\u201351.", "ArticleIdList": ["33402244", "10.5993/AJHB.45.1.11"]}, {"Citation": "McCann SE, Freudenheim JL, Marshall JR, Graham S. Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups. J Nutr. 2003;133(6):1937\u201342.", "ArticleIdList": ["12771342", "10.1093/jn/133.6.1937"]}, {"Citation": "Crane TE, Khulpateea BR, Alberts DS, Basen-Engquist K, Thomson CA. Dietary intake and ovarian cancer risk: a systematic review. Cancer Epidemiol Prev Biomarkers. 2014;23(2):255\u201373.", "ArticleIdList": ["10.1158/1055-9965.EPI-13-0515"]}, {"Citation": "Sturgeon SR, Ziegler RG, Brinton LA, Nasca PC, Mallin K, Gridley G. Diet and the risk of vulvar cancer. Ann Epidemiol. 1991;1(5):427\u201337.", "ArticleIdList": ["1669523", "10.1016/1047-2797(91)90012-2"]}, {"Citation": "Butler LM, Wu AH. Green and black tea in relation to gynecologic cancers. Mol Nutr Food Res. 2011;55(6):931\u201340.", "ArticleIdList": ["21595018", "4234042", "10.1002/mnfr.201100058"]}, {"Citation": "Zhou Y, Chlebowski R, LaMonte MJ, Bea JW, Qi L, Wallace R, et al. Body mass index, physical activity, and mortality in women diagnosed with ovarian cancer: results from the Women\u2019s Health Initiative. Gynecol Oncol. 2014;133(1):4\u201310.", "ArticleIdList": ["24680584", "4064800", "10.1016/j.ygyno.2014.01.033"]}, {"Citation": "Zamorano AS, Hagemann AR, Morrison L, Lee JA, Liao LM, Brinton LA, et al. Pre-diagnosis body mass index, physical activity and ovarian cancer mortality. Gynecol Oncol. 2019;155(1):105\u201311.", "ArticleIdList": ["31383570", "10.1016/j.ygyno.2019.07.025"]}, {"Citation": "Park S, Kim K, Ahn HK, Kim JW, Min G, Chung BH, et al. Impact of lifestyle intervention for patients with prostate cancer. Am J Health Behav. 2020;44(1):90\u20139.", "ArticleIdList": ["31783936", "10.5993/AJHB.44.1.10"]}, {"Citation": "Conroy MB, Sattelmair JR, Cook NR, Manson JE, Buring JE, Lee I-M. Physical activity, adiposity, and risk of endometrial cancer. Cancer Causes Control. 2009;20(7):1107\u201315.", "ArticleIdList": ["19247787", "2754728", "10.1007/s10552-009-9313-3"]}, {"Citation": "Seo S-S, Oh HY, Kim MK, Lee DO, Chung YK, Kim J-Y, et al. Combined effect of secondhand smoking and alcohol drinking on risk of persistent human papillomavirus infection. BioMed Res Int. 2019;2019:1\u20139."}, {"Citation": "Tworoger SS, Gertig DM, Gates MA, Hecht JL, Hankinson SE. Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer. Cancer. 2008;112(5):1169\u201377.", "ArticleIdList": ["18213613", "10.1002/cncr.23275"]}, {"Citation": "Je Y, DeVivo I, Giovannucci E. Long-term alcohol intake and risk of endometrial cancer in the nurses\u2019 health study, 1980\u20132010. Br J Cancer. 2014;111(1):186\u201394.", "ArticleIdList": ["24853180", "4090729", "10.1038/bjc.2014.257"]}, {"Citation": "Gosvig CF, Kjaer SK, Blaak\u00e6r J, H\u00f8gdall E, H\u00f8gdall C, Jensen A. Coffee, tea, and caffeine consumption and risk of epithelial ovarian cancer and borderline ovarian tumors: results from a Danish case-control study. Acta Oncol. 2015;54(8):1144\u201351.", "ArticleIdList": ["25629440", "10.3109/0284186X.2014.1001035"]}, {"Citation": "Je Y, Hankinson SE, Tworoger SS, DeVivo I, Giovannucci E. A prospective cohort study of coffee consumption and risk of endometrial cancer over a 26-year follow-up. Cancer Epidemio Prev Biomarkers. 2011;20(12):2487\u201395.", "ArticleIdList": ["10.1158/1055-9965.EPI-11-0766"]}, {"Citation": "Chiou W-Y, Chen C-A, Lee M-S, Lin H-Y, Li C-Y, Su Y-C, et al. Pelvic inflammatory disease increases the risk of a second primary malignancy in patients with cervical cancer treated by surgery alone. Medicine. 2016;95(47):e5409.", "ArticleIdList": ["27893679", "5134872", "10.1097/MD.0000000000005409"]}, {"Citation": "Parizi PK, Yarahmadi F, Tabar HM, Hosseini Z, Sarli A, Kia N, et al. MicroRNAs and target molecules in bladder cancer. Med Oncol. 2020;37(12):1\u201333.", "ArticleIdList": ["10.1007/s12032-020-01435-0"]}, {"Citation": "Lin H-W, Wang P-H, Lee C-Y, Huang J-Y, Yang S-F, Hsiao Y-H. The Risk of gynecologic and urinary tract cancer with pelvic inflammatory disease: a population-based cohort study. J Cancer. 2019;10(1):28.", "ArticleIdList": ["30662522", "6329849", "10.7150/jca.29278"]}, {"Citation": "Sayasneh A, Tsivos D, Crawford R. Endometriosis and ovarian cancer: a systematic review. ISRN Obstet Gynecol. 2011;2011:1\u20136.", "ArticleIdList": ["10.5402/2011/140310"]}, {"Citation": "Liu R, Tang S, Feng F, Liu C, Wang L, Zhao W, et al. Impact of endometriosis on risk of ovarian, endometrial and cervical cancers: a meta-analysis. Arch Gynecol Obstet. 2019;299(1):35\u201346.", "ArticleIdList": ["30460611", "10.1007/s00404-018-4968-1"]}, {"Citation": "Walker JL, Manetta A, Mannel RS, Berman ML, DiSaia PJ. The influence of endometriosis on the staging of cervical cancer. Obstet Gynecol. 1990;75(3 Pt 2):543\u20135.", "ArticleIdList": ["2304733"]}, {"Citation": "Burghaus S, H\u00e4berle L, Schrauder MG, Heusinger K, Thiel FC, Hein A, et al. Endometriosis as a risk factor for ovarian or endometrial cancer\u2014results of a hospital-based case\u2013control study. BMC Cancer. 2015;15(1):751.", "ArticleIdList": ["26487094", "4618513", "10.1186/s12885-015-1821-9"]}, {"Citation": "Crayford TJ, Campbell S, Bourne TH, Rawson HJ, Collins WP. Benign ovarian cysts and ovarian cancer: a cohort study with implications for screening. The Lancet. 2000;355(9209):1060\u20133.", "ArticleIdList": ["10.1016/S0140-6736(00)02038-9"]}, {"Citation": "Li H-Q, Thomas DB. Study TWHOC: tubal ligation and risk of cervical cancer. Contraception. 2000;61(5):323\u20138.", "ArticleIdList": ["10906503", "10.1016/S0010-7824(00)00111-6"]}, {"Citation": "Falconer H, Yin L, Altman D. Association between tubal ligation and endometrial cancer risk: a Swedish population-based cohort study. Int J Cancer. 2018;143(1):16\u201321.", "ArticleIdList": ["29388208", "10.1002/ijc.31287"]}, {"Citation": "Gaitskell K, Green J, Pirie K, Reeves G, Beral V, et al. Tubal ligation and ovarian cancer risk in a large cohort: substantial variation by histological type. Int J Cancer. 2016;138(5):1076\u201384.", "ArticleIdList": ["26378908", "10.1002/ijc.29856"]}, {"Citation": "Titus-Ernstoff L, Perez K, Cramer D, Harlow BL, Baron J, Greenberg E. Menstrual and reproductive factors in relation to ovarian cancer risk. Br J Cancer. 2001;84(5):714\u201321.", "ArticleIdList": ["11237375", "2363792", "10.1054/bjoc.2000.1596"]}, {"Citation": "Parazzini F, La Vecchia C, Negri E, Gentile A. Menstrual factors and the risk of epithelial ovarian cancer. J Clin Epidemiol. 1989;42(5):443\u20138.", "ArticleIdList": ["2732772", "10.1016/0895-4356(89)90134-0"]}, {"Citation": "Purdie DM, Bain CJ, Siskind V, Webb PM, Green AC. Ovulation and risk of epithelial ovarian cancer. Int J Cancer. 2003;104(2):228\u201332.", "ArticleIdList": ["12569579", "10.1002/ijc.10927"]}, {"Citation": "Xu WH, Xiang YB, Ruan ZX, Zheng W, Cheng JR, Dai Q, et al. Menstrual and reproductive factors and endometrial cancer risk: results from a population-based case-control study in urban Shanghai. Int J Cancer. 2004;108(4):613\u20139.", "ArticleIdList": ["14696129", "10.1002/ijc.11598"]}, {"Citation": "Wu Y, Sun W, Liu H, Zhang D. Age at menopause and risk of developing endometrial cancer: a meta-analysis. BioMed Res Int. 2019;2019:1\u201313."}, {"Citation": "Sharma P, Pattanshetty SM. A study on risk factors of cervical cancer among patients attending a tertiary care hospital: a case-control study. Clin Epidemiol Global Health. 2018;6(2):83\u20137.", "ArticleIdList": ["10.1016/j.cegh.2017.10.001"]}, {"Citation": "Hinkula M, Pukkala E, Kyyr\u00f6nen P, Laukkanen P, Koskela P, Paavonen J, et al. A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland. Br J Cancer. 2004;90(5):1025\u20139.", "ArticleIdList": ["14997202", "2410219", "10.1038/sj.bjc.6601650"]}, {"Citation": "Chen Q, Tong M, Guo F, Lau S, Zhao M. Parity correlates with the timing of developing endometrial cancer, but not subtype of endometrial cancer. J Cancer. 2015;6(11):1087.", "ArticleIdList": ["26516355", "4615343", "10.7150/jca.12736"]}, {"Citation": "Dossus L, Allen N, Kaaks R, Bakken K, Lund E, Tjonneland A, et al. Reproductive risk factors and endometrial cancer: the European prospective investigation into cancer and nutrition. Int J Cancer. 2010;127(2):442\u201351.", "ArticleIdList": ["19924816"]}, {"Citation": "Cho H-W, Ouh Y-T, Lee K-M, Han SW, Lee JK, Cho GJ, et al. Long-term effect of pregnancy-related factors on the development of endometrial neoplasia: a nationwide retrospective cohort study. PloS One. 2019;14(3):e0214600.", "ArticleIdList": ["30921436", "6438517", "10.1371/journal.pone.0214600"]}, {"Citation": "Whiteman DC, Siskind V, Purdie DM, Green AC. Timing of pregnancy and the risk of epithelial ovarian cancer. Cancer Epidemiol Prev Biomarkers. 2003;12(1):42\u20136."}, {"Citation": "Milne RL, Osorio A, Cajal TR, Baiget M, Lasa A, Diaz-Rubio E, et al. Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. 2010;119(1):221\u201332.", "ArticleIdList": ["19370414", "10.1007/s10549-009-0394-1"]}, {"Citation": "Gaitskell K, Green J, Pirie K, Reeves G, Beral V. OP26 parity and ovarian cancer in the million women study: variation by histological subtype. BMJ Publishing Group Ltd; 2014."}, {"Citation": "Kirschner MA. The role of hormones in the etiology of human breast cancer. Cancer. 1977;39(6):2716\u201326.", "ArticleIdList": ["326377", "10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3"]}, {"Citation": "Patil MB, Lavanya T, Kumari CM, Shetty SR, Gufran K, Viswanath V, et al. Serum ceruloplasmin as cancer marker in oral pre-cancers and cancers. J Carcinog. 2021;20:15.", "ArticleIdList": ["34729047", "8531576", "10.4103/jcar.jcar_10_21"]}, {"Citation": "Bittner JJ. The causes and control of mammary cancer in mice. na;1947."}, {"Citation": "Gierisch JM, Coeytaux RR, Urrutia RP, Havrilesky LJ, Moorman PG, Lowery WJ, et al. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol Prev Biomarkers. 2013;22(11):1931\u201343.", "ArticleIdList": ["10.1158/1055-9965.EPI-13-0298"]}, {"Citation": "Iversen L, Fielding S, Lidegaard \u00d8, M\u00f8rch LS, Skovlund CW, Hannaford PC. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study. BMJ. 2018;362:k3609.", "ArticleIdList": ["30257920", "6283376", "10.1136/bmj.k3609"]}, {"Citation": "Walling A. Relationship between estrogen therapy and cervical cancer. Am Family Physician. 1998;57(5):1137."}, {"Citation": "Brake T, Lambert PF. Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model. Proc Natl Acad Sci. 2005;102(7):2490\u20135.", "ArticleIdList": ["15699322", "548999", "10.1073/pnas.0409883102"]}, {"Citation": "Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol. 1995;85(2):304\u201313.", "ArticleIdList": ["7824251", "10.1016/0029-7844(94)00383-O"]}, {"Citation": "Fournier A, Dossus L, Mesrine S, Vilier A, Boutron-Ruault M-C, Clavel-Chapelon F, et al. Risks of endometrial cancer associated with different hormone replacement therapies in the E3N cohort, 1992\u20132008. Am J Epidemiol. 2014;180(5):508\u201317.", "ArticleIdList": ["25008104", "10.1093/aje/kwu146"]}, {"Citation": "Felix AS, Gaudet MM, Vecchia CL, Nagle CM, Shu XO, Weiderpass E, et al. Intrauterine devices and endometrial cancer risk: a pooled analysis of the epidemiology of endometrial cancer consortium. Int J Cancer. 2015;136(5):E410\u201322.", "ArticleIdList": ["25242594", "10.1002/ijc.29229"]}, {"Citation": "Wheeler LJ, Desanto K, Teal SB, Sheeder J, Guntupalli SR. Intrauterine device use and ovarian cancer risk: a systematic review and meta-analysis. Obstet Gynecol. 2019;134(4):791\u2013800.", "ArticleIdList": ["31503144", "10.1097/AOG.0000000000003463"]}, {"Citation": "Schiff M, Miller J, Masuk M, van Asselt KL, Altobelli KK, Wheeler CM, et al. Contraceptive and reproductive risk factors for cervical intraepithelial neoplasia in American Indian women. Int J Epidemiol. 2000;29(6):983\u201390.", "ArticleIdList": ["11101538", "10.1093/ije/29.6.983"]}, {"Citation": "Momenimovahed Z, Tiznobaik A, Salehiniya H. Do fertility drugs increase the risk of cancer? A review study. Front Endocrinol. 2019;10:313.", "ArticleIdList": ["10.3389/fendo.2019.00313"]}, {"Citation": "Reigstad M, Larsen IK, Myklebust T, Robsahm TE, Oldereid N, Omland A, et al. Cancer risk among parous women following assisted reproductive technology. Hum Reprod. 2015;30(8):1952\u201363.", "ArticleIdList": ["26113657", "4507330", "10.1093/humrep/dev124"]}, {"Citation": "Reigstad MM, Storeng R, Myklebust T\u00c5, Oldereid NB, Omland AK, Robsahm TE, et al. Cancer risk in women treated with fertility drugs according to parity status\u2014a registry-based cohort study. Cancer Epidemiol Prev Biomarkers. 2017;26(6):953\u201362.", "ArticleIdList": ["10.1158/1055-9965.EPI-16-0809"]}, {"Citation": "Kessous R, Davidson E, Meirovitz M, Sergienko R, Sheiner E. The risk of female malignancies after fertility treatments: a cohort study with 25-year follow-up. J Cancer Res Clin Oncol. 2016;142(1):287\u201393.", "ArticleIdList": ["26337160", "10.1007/s00432-015-2035-x"]}, {"Citation": "Dor J, Lerner-Geva L, Rabinovici J, Chetrit A, Levran D, Lunenfeld B, et al. Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. Fertil Steril. 2002;77(2):324\u20137.", "ArticleIdList": ["11821091", "10.1016/S0015-0282(01)02986-7"]}, {"Citation": "Venn A, Watson L, Bruinsma F, Giles G, Healy D. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet. 1999;354(9190):1586\u201390.", "ArticleIdList": ["10560672", "10.1016/S0140-6736(99)05203-4"]}, {"Citation": "Yli-Kuha A-N, Gissler M, Klemetti R, Luoto R, Hemminki E. Cancer morbidity in a cohort of 9175 Finnish women treated for infertility. Hum Reprod. 2012;27(4):1149\u201355.", "ArticleIdList": ["22343550", "10.1093/humrep/des031"]}, {"Citation": "Brinton LA, Trabert B, Shalev V, Lunenfeld E, Sella T, Chodick G. In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services. Fertil Steril. 2013;99(5):1189\u201396.", "ArticleIdList": ["23375197", "4030547", "10.1016/j.fertnstert.2012.12.029"]}, {"Citation": "Tung K-H, Wilkens LR, Wu AH, McDuffie K, Nomura AM, Kolonel LN, et al. Effect of anovulation factors on pre-and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis. Am J Epidemiol. 2005;161(4):321\u20139.", "ArticleIdList": ["15692075", "10.1093/aje/kwi046"]}, {"Citation": "Mandai M, Konishi I, Kuroda H, Fujii S. LH/hCG action and development of ovarian cancer\u2014a short review on biological and clinical/epidemiological aspects. Mol Cell Endocrinol. 2007;269(1\u20132):61\u20134.", "ArticleIdList": ["17353087", "10.1016/j.mce.2006.11.014"]}, {"Citation": "Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection among females in the United States. JAMA. 2007;297(8):813\u20139. https://doi.org/10.1001/jama.297.8.813 .", "ArticleIdList": ["10.1001/jama.297.8.813", "17327523"]}, {"Citation": "Olusola P, Banerjee HN, Philley JV, Dasgupta S. Human papilloma virus-associated cervical cancer and health disparities. Cells. 2019;8(6):622. https://doi.org/10.3390/cells8060622 .", "ArticleIdList": ["10.3390/cells8060622", "31234354", "6628030"]}, {"Citation": "Khan W, Augustine D, Rao RS, Patil S, Awan KH, Sowmya SV, et al. Lipid metabolism in cancer: a systematic review. J Carcinog. 2021;20:4.", "ArticleIdList": ["34321955", "8312377", "10.4103/jcar.JCar_15_20"]}, {"Citation": "Yang X, You Q, Yao G, Geng J, Ma R, Meng H. Evaluation of p16 in epithelial ovarian cancer for a 10-year study in Northeast China: significance of HPV in correlation with PD-L1 expression. Cancer Manag Res. 2020;12:6747\u201353. https://doi.org/10.2147/CMAR.S262678 .", "ArticleIdList": ["10.2147/CMAR.S262678", "32848457", "7425106"]}, {"Citation": "Halec G, Alemany L, Lloveras B, Schmitt M, Alejo M, Bosch FX, et al. Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer. J Pathol. 2014;234(4):441\u201351. https://doi.org/10.1002/path.4405 .", "ArticleIdList": ["10.1002/path.4405", "25043390"]}, {"Citation": "Olesen TB, Svahn MF, Faber MT, Duun-Henriksen AK, Junge J, Norrild B, et al. Prevalence of human papillomavirus in endometrial cancer: a systematic review and meta-analysis. Gynecol Oncol. 2014;134(1):206\u201315. https://doi.org/10.1016/j.ygyno.2014.02.040 .", "ArticleIdList": ["10.1016/j.ygyno.2014.02.040", "24607284"]}, {"Citation": "Stelzle D, Tanaka LF, Lee KK, Ibrahim Khalil A, Baussano I, Shah ASV, et al. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2021;9(2):e161\u20139. https://doi.org/10.1016/S2214-109X(20)30459-9 .", "ArticleIdList": ["10.1016/S2214-109X(20)30459-9", "33212031"]}, {"Citation": "de Zelmanowicz A, Hildesheim A. Family history of cancer as a risk factor for cervical carcinoma: a review of the literature. Papillomavirus Rep. 2004;15(3):113\u201320.", "ArticleIdList": ["10.1179/095741904225005115"]}, {"Citation": "Khaledi A, Khademi F, Esmaeili D, Esmaeili S-A, Rostami H. The role of HPaA protein as candidate vaccine against Helicobacter pylori. Der Pharma Chemica. 2016;8(3):235\u20137."}, {"Citation": "Zelmanowicz ADM, Schiffman M, Herrero R, Goldstein AM, Sherman ME, Burk RD, et al. Family history as a co-factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: Results from two studies conducted in Costa Rica and the United States. Int J Cancer. 2005;116(4):599\u2013605.", "ArticleIdList": ["15818615", "10.1002/ijc.21048"]}, {"Citation": "Win AK, Reece JC, Ryan S. Family history and risk of endometrial cancer: a systematic review and meta-analysis. Obstet Gynecol. 2015;125(1):89\u201398.", "ArticleIdList": ["25560109", "10.1097/AOG.0000000000000563"]}, {"Citation": "Easton D, Ford D, Matthews F, Peto J. The genetic epidemiology of ovarian cancer. In: Sharp F, Mason P, Blackett T, Berek J, editors. Ovarian cancer 3. Springer; 1995. p. 3\u201312.", "ArticleIdList": ["10.1007/978-1-4757-0136-4_1"]}, {"Citation": "Thompson D, Easton DF. Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst. 2002;94(18):1358\u201365.", "ArticleIdList": ["12237281", "10.1093/jnci/94.18.1358"]}, {"Citation": "Narayan G, Arias-Pulido H, Nandula SV, Basso K, Sugirtharaj DD, Vargas H, et al. Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer. Can Res. 2004;64(9):2994\u20137.", "ArticleIdList": ["10.1158/0008-5472.CAN-04-0245"]}, {"Citation": "Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst. 2000;92(7):564\u20139.", "ArticleIdList": ["10749912", "10.1093/jnci/92.7.564"]}, {"Citation": "Staff S, Isola J, Tanner M. Haplo-insufficiency of BRCA1 in sporadic breast cancer. Can Res. 2003;63(16):4978\u201383."}, {"Citation": "Narayan G, Arias-Pulido H, Koul S, Vargas H, Zhang FF, Villella J, et al. Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome. Mol Cancer. 2003;2(1):24.", "ArticleIdList": ["12773202", "156646", "10.1186/1476-4598-2-24"]}, {"Citation": "Johannsson O, Loman N, M\u00f6ller T, Kristoffersson U, Borg \u00c5, Olsson H. Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers. Eur J Cancer. 1999;35(8):1248\u201357.", "ArticleIdList": ["10615237", "10.1016/S0959-8049(99)00135-5"]}, {"Citation": "Miyai K, Furugen Y, Matsumoto T, Iwabuchi K, Hirose S, Kinoshita K, et al. Loss of heterozygosity analysis in uterine cervical adenocarcinoma. Gynecol Oncol. 2004;94(1):115\u201320.", "ArticleIdList": ["15262128", "10.1016/j.ygyno.2004.04.013"]}, {"Citation": "Neff RT, Senter L, Salani R. BRCA mutation in ovarian cancer: testing, implications and treatment considerations. Therap Adv Med Oncol. 2017;9(8):519\u201331.", "ArticleIdList": ["10.1177/1758834017714993"]}, {"Citation": "Ramus SJ, Gayther SA. The contribution of BRCA1 and BRCA2 to ovarian cancer. Mol Oncol. 2009;3(2):138\u201350.", "ArticleIdList": ["19383375", "5527889", "10.1016/j.molonc.2009.02.001"]}, {"Citation": "Sun G, Zhang Q, Liu Y, Xie P. Role of phosphatidylinositol 3-kinase and its catalytic unit PIK3CA in cervical cancer: a mini-review. Appl Bionics Biomech. 2022;2022:1\u20136."}, {"Citation": "Crispens MA. Endometrial and ovarian cancer in lynch syndrome. Clin Colon Rectal Surg. 2012;25(02):097\u2013102.", "ArticleIdList": ["10.1055/s-0032-1313780"]}, {"Citation": "Nakamura K, Banno K, Yanokura M, Iida M, Adachi M, Masuda K, et al. Features of ovarian cancer in Lynch syndrome. Mol Clin Oncol. 2014;2(6):909\u201316.", "ArticleIdList": ["25279173", "4179837", "10.3892/mco.2014.397"]}, {"Citation": "Cole AJ, Dwight T, Gill AJ, Dickson K-A, Zhu Y, Clarkson A, et al. Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing. Sci Rep. 2016;6(1):1\u201312.", "ArticleIdList": ["10.1038/srep26191"]}, {"Citation": "Lu KH. Hereditary gynecologic cancer: risk, prevention and management. NY: CRC Press; 2008.", "ArticleIdList": ["10.3109/9781420052886"]}, {"Citation": "Djordjevic B, Hennessy BT, Li J, Barkoh BA, Luthra R, Mills GB, et al. Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing. Mod Pathol. 2012;25(5):699\u2013708.", "ArticleIdList": ["22301702", "3341518", "10.1038/modpathol.2011.208"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "10", "Day": "26"}, {"Year": "2023", "Month": "1", "Day": "12"}, {"Year": "2023", "Month": "2", "Day": "9", "Hour": "11", "Minute": "20"}, {"Year": "2023", "Month": "2", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "14", "Hour": "6", "Minute": "0"}], "PublicationStatus": "epublish", "ArticleIdList": ["36757546", "10.1007/s12032-023-01957-3", "10.1007/s12032-023-01957-3"]}}], "PubmedBookArticle": []}